IT1299969B1 - Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica. - Google Patents

Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.

Info

Publication number
IT1299969B1
IT1299969B1 IT98BO000239A ITBO980239A IT1299969B1 IT 1299969 B1 IT1299969 B1 IT 1299969B1 IT 98BO000239 A IT98BO000239 A IT 98BO000239A IT BO980239 A ITBO980239 A IT BO980239A IT 1299969 B1 IT1299969 B1 IT 1299969B1
Authority
IT
Italy
Prior art keywords
sulodexide
contain
treatment
diabetic retinopathy
specialties
Prior art date
Application number
IT98BO000239A
Other languages
English (en)
Inventor
Ernesto Palazzini
Flavia Rubbi
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO980239A0 publication Critical patent/ITBO980239A0/it
Priority to IT98BO000239A priority Critical patent/IT1299969B1/it
Priority to EP99103981A priority patent/EP0950413A3/en
Priority to US09/266,385 priority patent/US6080732A/en
Priority to IL12896699A priority patent/IL128966A/xx
Priority to NZ334660A priority patent/NZ334660A/xx
Priority to AU22462/99A priority patent/AU755534B2/en
Priority to ZA9902406A priority patent/ZA992406B/xx
Priority to CA002267543A priority patent/CA2267543C/en
Priority to JP10648599A priority patent/JP4578593B2/ja
Publication of ITBO980239A1 publication Critical patent/ITBO980239A1/it
Application granted granted Critical
Publication of IT1299969B1 publication Critical patent/IT1299969B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT98BO000239A 1998-04-15 1998-04-15 Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica. IT1299969B1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT98BO000239A IT1299969B1 (it) 1998-04-15 1998-04-15 Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.
EP99103981A EP0950413A3 (en) 1998-04-15 1999-03-10 Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
US09/266,385 US6080732A (en) 1998-04-15 1999-03-11 Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
IL12896699A IL128966A (en) 1998-04-15 1999-03-12 Pharmaceutical composition containing sulodexide for treatment of diabetic retinopathy
NZ334660A NZ334660A (en) 1998-04-15 1999-03-15 use of sulodexide to treat diabetic retinopathy
AU22462/99A AU755534B2 (en) 1998-04-15 1999-03-29 Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
ZA9902406A ZA992406B (en) 1998-04-15 1999-03-29 Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy.
CA002267543A CA2267543C (en) 1998-04-15 1999-03-30 Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
JP10648599A JP4578593B2 (ja) 1998-04-15 1999-04-14 糖尿病性網膜症治療のためのスロデキサイドを含有する医薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98BO000239A IT1299969B1 (it) 1998-04-15 1998-04-15 Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.

Publications (3)

Publication Number Publication Date
ITBO980239A0 ITBO980239A0 (it) 1998-04-15
ITBO980239A1 ITBO980239A1 (it) 1999-10-15
IT1299969B1 true IT1299969B1 (it) 2000-04-04

Family

ID=11343111

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98BO000239A IT1299969B1 (it) 1998-04-15 1998-04-15 Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.

Country Status (9)

Country Link
US (1) US6080732A (it)
EP (1) EP0950413A3 (it)
JP (1) JP4578593B2 (it)
AU (1) AU755534B2 (it)
CA (1) CA2267543C (it)
IL (1) IL128966A (it)
IT (1) IT1299969B1 (it)
NZ (1) NZ334660A (it)
ZA (1) ZA992406B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
AU2005262390B2 (en) * 2004-07-01 2011-09-22 Atherogenics, Inc. Compounds and methods for treating diabetic vascular diseases
BRPI0613677A2 (pt) * 2005-07-22 2011-01-25 Trf Pharma Inc método para tratar doença de célula falsiforme e sequelas da doença de célula falsiforme
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
IT1401253B1 (it) * 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.

Also Published As

Publication number Publication date
IL128966A (en) 2003-05-29
ITBO980239A0 (it) 1998-04-15
AU2246299A (en) 1999-10-28
JPH11349486A (ja) 1999-12-21
JP4578593B2 (ja) 2010-11-10
NZ334660A (en) 2000-10-27
AU755534B2 (en) 2002-12-12
EP0950413A3 (en) 1999-12-08
ITBO980239A1 (it) 1999-10-15
US6080732A (en) 2000-06-27
CA2267543A1 (en) 1999-10-15
ZA992406B (en) 1999-10-01
IL128966A0 (en) 2000-02-17
EP0950413A2 (en) 1999-10-20
CA2267543C (en) 2008-02-12

Similar Documents

Publication Publication Date Title
PT1083889E (pt) Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DK0445255T4 (da) Anvendelse af hyaluronsyre i kombination med ascorbinsyre, antitumormidler og/eller NSAID's til behandling af cancer
DE69917477D1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
DK0745396T3 (da) Blodpumpe og anvendelse deraf
IS6819A (is) Notkun rosúvastatíns (ZD-4522) í meðhöndlun arfblandaðrar og ættgengrar kólesterólhækkunar
ITBO930205A0 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
ITBO910163A1 (it) Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
ITRM920731A1 (it) Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
ITTO20001156A0 (it) Apparecchiatura per il trattamento di disgregazione di campioni biologici e dispositivo disgregatore per l'impiego in detta apparecchiatura.
BR0116972A (pt) Métodos e dispositivos para administração de substâncias na camada intradérmica da pele para absorção sistêmica
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
IT1299969B1 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.
PL311031A1 (en) Use of concentrates comprising vwf in complex therapy in case of treatment by using anticoagulants and fibrinolitic drugs
DE69021304D1 (de) Vorbeugendes und therapeutisches Mittel gegen Hepatitis.
ITRM920693A0 (it) Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.
IT1302920B1 (it) Uso della propoli nel trattamento della vitiligine e della psoriasi.
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
IT8805223A0 (it) Diffusore di vapori profumati e medicali, realizzato mediante l'uso di elementi costruiti in metallo, preferibilmente inossidabile
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
TR199901676A3 (tr) Siddetli agrilarin giderilmesinde steroid olmayan enflamasyona karsi ilaçlarin kullanimi.
IT1280794B1 (it) Dispositivo di osteotomia e osteosintesi.
IT1319289B1 (it) Dispositivo di supporto atto ad essere impiegato nel campodell'arredamento di semplice e sicuro montaggio

Legal Events

Date Code Title Description
0001 Granted